Company Monitoring Page for Roche

latest headlines for company on cafepharma

GlaxoSmithKline's 4.8% Yield Makes It Attractive With Or Without Human Genome Takeover
Seeking Alpha
Tue, 05/15/12 - 10:40 am
Tags:
GSK, Human Genome Sciences, Novartis, Pfizer, Roche
Cancer Tools Help Roche Push Ahead With Alzheimer’s Drug
Bloomberg
Mon, 05/14/12 - 10:17 am
Tags:
Roche, Alzheimer's disease, bapineuzumab
Bright Future Ahead Of Abbott Despite Mounting Competition
Seeking Alpha
Tue, 05/8/12 - 07:17 pm
Tags:
Abbott Laboratories, Merck, Nestle, Pfizer, Roche, Sanofi
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Tags:
Roche, Merck, dalcetrapib, Abbott Laboratories, Bristol-Myers Squibb, Gilead, Eli Lilly, Pfizer, Sanofi, Illumina
Roche Drops After Halting Cholesterol Drug Development
Bloomberg
Mon, 05/7/12 - 10:58 am
Tags:
Roche, dalcetrapib
Diving for Dividend Growth in Big Pharma
Motley Fool
Fri, 05/4/12 - 10:40 am
Tags:
dividends, GSK, Novartis, AstraZeneca, Sanofi, Abbott Laboratories, Roche, Bayer
Avastin, Lucentis equally effective at improving vision, big study finds
Fierce Pharma
Tue, 05/1/12 - 12:39 pm
Tags:
Lucentis, Avastin, Roche, Novartis, macular degeneration
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Mon, 04/30/12 - 10:13 am
Tags:
Eli Lilly, Merck, Northwest Biotherapeutics, Roche, brain cancer, Temodar, Erbitux, DCVax, Avastin
Drug Companies in M&A Rush
WSJ Online
Wed, 04/25/12 - 10:24 am
Tags:
M&A, Watson Pharmaceuticals, Actavis, Ardea, AstraZeneca, Roche, Illumina, GSK, Human Genome Sciences
Illumina And Human Genome: Reasons For Rejections Of Takeovers
Seeking Alpha
Mon, 04/23/12 - 12:15 pm
Tags:
M&A, Illumina, Roche, Human Genome Sciences, GSK
Galena Biopharma: How Long Can Big Pharma Wait?
Seeking Alpha
Mon, 04/23/12 - 11:10 am
Tags:
Galena Biopharma, Roche, NeuVax, breast cancer
Roche talks to Illumina rivals after drops bid: paper
Yahoo/Reuters
Sun, 04/22/12 - 12:06 pm
Tags:
Roche, Illumina, M&A
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
Tags:
GS-7977, Vertex Pharmaceuticals, hepatitis C, Roche, Bristol-Myers Squibb, Merck, Gilead Sciences, JNJ
This Takeover Is Off the Table. Maybe.
Motley Fool
Fri, 04/20/12 - 10:35 am
Tags:
M&A, Roche, Illumina
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
Tags:
BB1608, Boston Biomedical, Dainippon Sumitomo, cabozantinib, Exelixis, ONYX Pharmaceuticals, Carfilzomib, Medivation, Astellas, Enzalutamide, Ariad Pharmaceuticals, Ponatinib, Bayer, regorafenib, Oncovex, Amgen, Roche, Genentech, T-DM1, Immunogen, Aveo, tivozanib, Zaltrap, Sanofi, Regeneron
Roche not to extend tender offer for Illumina
Markewatch
Wed, 04/18/12 - 10:02 am
Tags:
Roche, M&A, Illumina
Illumina Win in Board Contest May Signal Long Roche Fight
Bloomberg
Tue, 04/17/12 - 10:29 am
Tags:
Roche, M&A, Illumina
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sun, 04/15/12 - 12:23 pm
Tags:
Erivedge, Curis, Roche, basal cell carcinoma
Roche Sales Slip, But Hints at Willingness to Lift Illumina Offer
FOX Business
Thu, 04/12/12 - 11:32 am
Tags:
Roche, Illumina, earnings, M&A
Roche Willing to Consider Added ‘Value’ in Illumina Bid
Bloomberg
Sat, 04/7/12 - 11:52 am
Tags:
Roche, Illumina, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.